Angelina Jolie has ovaries, fallopian tubes removed over cancer concerns
the ONA take:
Actress Angelina Jolie announced Tuesday that she underwent surgery to remove her fallopian tubes and ovaries out of fear of a hereditary form of cancer.
Having lost her mother, grandmother, and aunt to cancer, Jolie underwent a double mastectomy 2 years ago over similar concerns. Jolie opted to have her ovaries and fallopian tubes last weeks after a blood test revealed that she may be in the early stages of cancer.
After Jolie underwent the procedure to remove both of her breasts, the pros and cons of preventative measures were pushed into the spotlight, ultimately causing the "Angelina Jolie effect," in which there was an increase in women with genuine concerns about their family history of breast cancer seeking advice from health care professionals. Her announcement could produce the same effect for women concerned about their risk of ovarian cancer.
Further tests showed that the actress was not actually in the early stages of cancer, but she opted for the surgery before of her family history and because she carries the BRCA1 gene mutation that increases her risk of developing ovarian cancer by 50% and breast cancer by 87%.
Actress Angelina Jolie underwent surgery to remove her fallopian tubes and ovaries out of fear of a hereditary form of cancer.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|